Could Pharmacogenetic Dosing Reduce Warfarin-Related Adverse Events?
March 20th 2017Personalizing doses of warfarin through genetic testing helped reduce the risk of combined adverse events in patients undergoing elective orthopedic surgery, according to data presented at the American College of Cardiology's 66th Annual Scientific Session.
Read More
Omega-3 Fish Oil: Insufficient Evidence of Heart Disease Prevention
March 20th 2017The American Heart Association (AHA) has published a new science advisory stating that there is not enough evidence to support the use of fish oil supplementation as a primary prevention of cardiovascular disease in the general population.
Read More